登录

Corui Technology Closed on Pre-A Round Financing of 10 Million Yuan

作者: Mailman 2019-09-19 18:00
珂睿科技
http://www.coruitech.com/
企业数据由 动脉橙 提供支持
色谱仪器研发、制造销售商 | A轮 | 运营中
中国-四川
2024-02-16
融资金额:数千万人民币
博行资本
查看

According to Lieyunwang, Chengdu Corui Technology Co., LTD (Corui Technology) announced that it has completed the Pre-A round financing of 10 million yuan from Jiangning Science and Technology Venture Capital. 


As an enterprise of domestic scientific analysis instruments that develops rapidly, Corui Technology focuses on the domestic alternative market of chromatographs in China. In July 2018, Corui Technology closed on angel round financing from Future Capital.


Corui Technology was founded in August 2016. Its UHPLC GEMINI series is the first independently developed ultra-high-performance liquid chromatographs in China. Corui currently has 13 software copyrights, 12 patents, and another 5 invention patents in the substantive examination stage.


"With this fund, Corui will quickly build a sales network in east and south China, and accelerate the commercialization of the new product--blood concentration detector based on two-dimensional liquid chromatography and the development of related methods," said Wang Penghui, the CTO of Corui Technology.


Future Capital believes that China relies heavily on the import of liquid chromatography. The import equipment price is more than 700,000 yuan, while the domestic equipment is mostly low-end and low-priced products with the price below 100,000 yuan. That is to say, there is a huge domestic alternative market for chromatographs in China. It has been verified that the performance of the ultra-liquid chromatography instruments produced by Corui can reach the top of imported instruments, and provide better services, such as short delivery time, fast response to maintenance and so on.


>>>>

About Jiangning Science and Technology Venture Capital


Nanjing Jiangning Science and Technology Venture Capital Group Co., LTD. (Jiangning Science and Technology Venture Capital) was registered on August 29, 2011, with the registered capital of 200 million yuan. The company is directly controlled by the People's Government of Jiangning District, mainly for small and medium enterprises to provide debt and equity financing, business consulting and services such as industry investment.

相关赛道 其它诊断设备
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】铂桐医疗完成超千万元融资,打造数字医疗赋能的疼痛管理平台标杆

Peijia Medical Raises HK$2.34B in Hong Kong IPO

Xinjunte Snags ¥10M in Series A Funding Round, Focusing on Orthopedic Surgery Robots

Wellgrow Techonogy Snags $1.4M in Series A Financing, Led by Green Pine Capital Partners

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

生物制药公司Linnaeus完成1200万美元B轮融资,开发激素敏感性肿瘤治疗药物

2019-09-19
下一篇

盟科医药宣布新型抗菌药康泰唑胺(Contezolid)针对复杂性皮肤及软组织感染的中国三期临床试验获得积极结果

2019-09-19